25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BORA PHARMACEUTICALS LTD
Buy, Hold or Sell?

Let's analyze BORA PHARMACEUTICALS LTD together

I guess you are interested in BORA PHARMACEUTICALS LTD. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BORA PHARMACEUTICALS LTD. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BORA PHARMACEUTICALS LTD

I send you an email if I find something interesting about BORA PHARMACEUTICALS LTD.

1. Quick Overview

1.1. Quick analysis of BORA PHARMACEUTICALS LTD (30 sec.)










1.2. What can you expect buying and holding a share of BORA PHARMACEUTICALS LTD? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.19
When do you have the money?
1 year
How often do you get paid?
25.0%

What is your share worth?

Current worth
NT$119.00
Expected worth in 1 year
NT$170.01
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
NT$57.04
Return On Investment
7.2%

For what price can you sell your share?

Current Price per Share
NT$788.00
Expected price per share
NT$700.00 - NT$960.06
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of BORA PHARMACEUTICALS LTD (5 min.)




Live pricePrice per Share (EOD)
NT$788.00

2.2. Growth of BORA PHARMACEUTICALS LTD (5 min.)




Is BORA PHARMACEUTICALS LTD growing?

Current yearPrevious yearGrowGrow %
How rich?$381.4m$311.7m$26.9m8.0%

How much money is BORA PHARMACEUTICALS LTD making?

Current yearPrevious yearGrowGrow %
Making money$24.5m$20.8m$3.7m15.1%
Net Profit Margin22.5%18.1%--

How much money comes from the company's main activities?

2.3. Financial Health of BORA PHARMACEUTICALS LTD (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of BORA PHARMACEUTICALS LTD?

Welcome investor! BORA PHARMACEUTICALS LTD's management wants to use your money to grow the business. In return you get a share of BORA PHARMACEUTICALS LTD.

First you should know what it really means to hold a share of BORA PHARMACEUTICALS LTD. And how you can make/lose money.

Speculation

The Price per Share of BORA PHARMACEUTICALS LTD is NT$788.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BORA PHARMACEUTICALS LTD.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BORA PHARMACEUTICALS LTD, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$119.00. Based on the TTM, the Book Value Change Per Share is NT$12.75 per quarter. Based on the YOY, the Book Value Change Per Share is NT$17.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$1.51 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BORA PHARMACEUTICALS LTD.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.350.0%0.230.0%0.200.0%0.220.0%0.220.0%
Usd Book Value Change Per Share0.310.0%0.390.0%0.520.1%0.460.1%0.460.1%
Usd Dividend Per Share0.000.0%0.050.0%0.020.0%0.030.0%0.030.0%
Usd Total Gains Per Share0.310.0%0.440.1%0.540.1%0.490.1%0.490.1%
Usd Price Per Share25.53-16.33-0.00-8.17-8.17-
Price to Earnings Ratio18.41-18.12-0.00-9.06-9.06-
Price-to-Total Gains Ratio83.54--150.21--150.21--150.21-
Price to Book Ratio6.97-4.69-0.00-2.34-2.34-
Price-to-Total Gains Ratio83.54--150.21--150.21--150.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share24.2704
Number of shares41
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.03
Usd Book Value Change Per Share0.390.46
Usd Total Gains Per Share0.440.49
Gains per Quarter (41 shares)18.0120.10
Gains per Year (41 shares)72.0380.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18646257570
21512913411150150
32319320616225230
43025827821301310
53832235026376390
64638642232451470
75345149437526550
86151556642601630
96958063848676710
107664471053751790

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%6.02.00.075.0%6.02.00.075.0%6.02.00.075.0%6.02.00.075.0%
Dividend per Share1.00.03.025.0%2.00.06.025.0%2.00.06.025.0%2.00.06.025.0%2.00.06.025.0%
Total Gains per Share3.01.00.075.0%6.02.00.075.0%6.02.00.075.0%6.02.00.075.0%6.02.00.075.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BORA PHARMACEUTICALS LTD compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--9.92312.752-22%16.997-42%14.875-33%14.875-33%
Book Value Per Share--118.997104.988+13%98.962+20%101.975+17%101.975+17%
Current Ratio--1.1941.215-2%1.135+5%1.175+2%1.175+2%
Debt To Asset Ratio--0.7140.628+14%0.549+30%0.589+21%0.589+21%
Debt To Equity Ratio--3.2342.214+46%2.433+33%2.324+39%2.324+39%
Dividend Per Share---1.507-100%0.584-100%1.046-100%1.046-100%
Eps--11.2607.629+48%6.609+70%7.119+58%7.119+58%
Free Cash Flow Per Share---21.421-1.491-93%9.891-317%4.200-610%4.200-610%
Free Cash Flow To Equity Per Share--63.16125.147+151%14.270+343%19.708+220%19.708+220%
Gross Profit Margin--0.7530.769-2%0.848-11%0.809-7%0.809-7%
Market Cap80600580000.000-7%86273058412.00055765537103.000+55%-+100%27882768551.500+209%27882768551.500+209%
Net Profit Margin--0.2330.225+4%0.181+29%0.203+15%0.203+15%
Operating Margin--0.1700.266-36%0.253-33%0.259-34%0.259-34%
Operating Ratio--0.8520.697+22%0.715+19%0.706+21%0.706+21%
Pb Ratio6.622-5%6.9674.687+49%-+100%2.344+197%2.344+197%
Pe Ratio17.496-5%18.40618.124+2%-+100%9.062+103%9.062+103%
Price Per Share788.000-5%829.000530.250+56%-+100%265.125+213%265.125+213%
Price To Free Cash Flow Ratio-9.197+5%-9.6755.766-268%--100%2.883-436%2.883-436%
Price To Total Gains Ratio79.409-5%83.541-150.208+280%---150.208+280%-150.208+280%
Quick Ratio--1.0451.018+3%0.939+11%0.978+7%0.978+7%
Return On Assets--0.0270.026+4%0.030-11%0.028-4%0.028-4%
Return On Equity--0.1220.091+35%0.132-7%0.111+10%0.111+10%
Total Gains Per Share--9.92314.259-30%17.581-44%15.920-38%15.920-38%
Usd Book Value--381423935.200338720104.800+13%311767332.800+22%325243718.800+17%325243718.800+17%
Usd Book Value Change Per Share--0.3060.393-22%0.524-42%0.458-33%0.458-33%
Usd Book Value Per Share--3.6653.234+13%3.048+20%3.141+17%3.141+17%
Usd Dividend Per Share---0.046-100%0.018-100%0.032-100%0.032-100%
Usd Eps--0.3470.235+48%0.204+70%0.219+58%0.219+58%
Usd Free Cash Flow---68661177.200-4456375.000-94%31160706.500-320%13352165.750-614%13352165.750-614%
Usd Free Cash Flow Per Share---0.660-0.046-93%0.305-317%0.129-610%0.129-610%
Usd Free Cash Flow To Equity Per Share--1.9450.775+151%0.440+343%0.607+220%0.607+220%
Usd Market Cap2482497864.000-7%2657210199.0901717578542.772+55%-+100%858789271.386+209%858789271.386+209%
Usd Price Per Share24.270-5%25.53316.332+56%-+100%8.166+213%8.166+213%
Usd Profit--36091902.00024537797.900+47%20821708.600+73%22679753.250+59%22679753.250+59%
Usd Revenue--154841178.800109076467.500+42%122750951.400+26%115913709.450+34%115913709.450+34%
Usd Total Gains Per Share--0.3060.439-30%0.541-44%0.490-38%0.490-38%
 EOD+3 -5MRQTTM+18 -18YOY+16 -195Y+18 -1810Y+18 -18

3.3 Fundamental Score

Let's check the fundamental score of BORA PHARMACEUTICALS LTD based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.496
Price to Book Ratio (EOD)Between0-16.622
Net Profit Margin (MRQ)Greater than00.233
Operating Margin (MRQ)Greater than00.170
Quick Ratio (MRQ)Greater than11.045
Current Ratio (MRQ)Greater than11.194
Debt to Asset Ratio (MRQ)Less than10.714
Debt to Equity Ratio (MRQ)Less than13.234
Return on Equity (MRQ)Greater than0.150.122
Return on Assets (MRQ)Greater than0.050.027
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of BORA PHARMACEUTICALS LTD based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.101
Ma 20Greater thanMa 50751.800
Ma 50Greater thanMa 100748.720
Ma 100Greater thanMa 200774.901
OpenGreater thanClose780.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About BORA PHARMACEUTICALS LTD

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services. In addition, it provides food and vitamin supplements, and skincare products; and biotechnical services. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.

Fundamental data was last updated by Penke on 2024-11-14 06:55:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit BORA PHARMACEUTICALS LTD earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare BORA PHARMACEUTICALS LTD to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 23.3% means that NT$0.23 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BORA PHARMACEUTICALS LTD:

  • The MRQ is 23.3%. The company is making a huge profit. +2
  • The TTM is 22.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.3%TTM22.5%+0.8%
TTM22.5%YOY18.1%+4.4%
TTM22.5%5Y20.3%+2.2%
5Y20.3%10Y20.3%0.0%
4.3.1.2. Return on Assets

Shows how efficient BORA PHARMACEUTICALS LTD is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BORA PHARMACEUTICALS LTD to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.7% Return on Assets means that BORA PHARMACEUTICALS LTD generated NT$0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BORA PHARMACEUTICALS LTD:

  • The MRQ is 2.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.6%+0.1%
TTM2.6%YOY3.0%-0.4%
TTM2.6%5Y2.8%-0.2%
5Y2.8%10Y2.8%0.0%
4.3.1.3. Return on Equity

Shows how efficient BORA PHARMACEUTICALS LTD is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BORA PHARMACEUTICALS LTD to the Drug Manufacturers - Specialty & Generic industry mean.
  • 12.2% Return on Equity means BORA PHARMACEUTICALS LTD generated NT$0.12 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BORA PHARMACEUTICALS LTD:

  • The MRQ is 12.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 9.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.2%TTM9.1%+3.2%
TTM9.1%YOY13.2%-4.1%
TTM9.1%5Y11.1%-2.1%
5Y11.1%10Y11.1%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BORA PHARMACEUTICALS LTD.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient BORA PHARMACEUTICALS LTD is operating .

  • Measures how much profit BORA PHARMACEUTICALS LTD makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BORA PHARMACEUTICALS LTD to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 17.0% means the company generated NT$0.17  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BORA PHARMACEUTICALS LTD:

  • The MRQ is 17.0%. The company is operating efficient. +1
  • The TTM is 26.6%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ17.0%TTM26.6%-9.6%
TTM26.6%YOY25.3%+1.3%
TTM26.6%5Y25.9%+0.7%
5Y25.9%10Y25.9%0.0%
4.3.2.2. Operating Ratio

Measures how efficient BORA PHARMACEUTICALS LTD is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.85 means that the operating costs are NT$0.85 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of BORA PHARMACEUTICALS LTD:

  • The MRQ is 0.852. The company is less efficient in keeping operating costs low.
  • The TTM is 0.697. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.852TTM0.697+0.155
TTM0.697YOY0.715-0.017
TTM0.6975Y0.706-0.009
5Y0.70610Y0.7060.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BORA PHARMACEUTICALS LTD.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if BORA PHARMACEUTICALS LTD is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.19 means the company has NT$1.19 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of BORA PHARMACEUTICALS LTD:

  • The MRQ is 1.194. The company is just able to pay all its short-term debts.
  • The TTM is 1.215. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.194TTM1.215-0.021
TTM1.215YOY1.135+0.080
TTM1.2155Y1.175+0.040
5Y1.17510Y1.1750.000
4.4.3.2. Quick Ratio

Measures if BORA PHARMACEUTICALS LTD is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BORA PHARMACEUTICALS LTD to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.05 means the company can pay off NT$1.05 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BORA PHARMACEUTICALS LTD:

  • The MRQ is 1.045. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.018. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.045TTM1.018+0.027
TTM1.018YOY0.939+0.080
TTM1.0185Y0.978+0.040
5Y0.97810Y0.9780.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BORA PHARMACEUTICALS LTD.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of BORA PHARMACEUTICALS LTD assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BORA PHARMACEUTICALS LTD to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.71 means that BORA PHARMACEUTICALS LTD assets are financed with 71.4% credit (debt) and the remaining percentage (100% - 71.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BORA PHARMACEUTICALS LTD:

  • The MRQ is 0.714. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.628. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.714TTM0.628+0.086
TTM0.628YOY0.549+0.080
TTM0.6285Y0.589+0.040
5Y0.58910Y0.5890.000
4.5.4.2. Debt to Equity Ratio

Measures if BORA PHARMACEUTICALS LTD is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BORA PHARMACEUTICALS LTD to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 323.4% means that company has NT$3.23 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BORA PHARMACEUTICALS LTD:

  • The MRQ is 3.234. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.214. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ3.234TTM2.214+1.020
TTM2.214YOY2.433-0.219
TTM2.2145Y2.324-0.110
5Y2.32410Y2.3240.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings BORA PHARMACEUTICALS LTD generates.

  • Above 15 is considered overpriced but always compare BORA PHARMACEUTICALS LTD to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 18.41 means the investor is paying NT$18.41 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BORA PHARMACEUTICALS LTD:

  • The EOD is 17.496. Based on the earnings, the company is fair priced.
  • The MRQ is 18.406. Based on the earnings, the company is fair priced.
  • The TTM is 18.124. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD17.496MRQ18.406-0.910
MRQ18.406TTM18.124+0.282
TTM18.124YOY-+18.124
TTM18.1245Y9.062+9.062
5Y9.06210Y9.0620.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BORA PHARMACEUTICALS LTD:

  • The EOD is -9.197. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.675. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 5.766. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-9.197MRQ-9.675+0.479
MRQ-9.675TTM5.766-15.441
TTM5.766YOY-+5.766
TTM5.7665Y2.883+2.883
5Y2.88310Y2.8830.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of BORA PHARMACEUTICALS LTD is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 6.97 means the investor is paying NT$6.97 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of BORA PHARMACEUTICALS LTD:

  • The EOD is 6.622. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.967. Based on the equity, the company is overpriced. -1
  • The TTM is 4.687. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD6.622MRQ6.967-0.345
MRQ6.967TTM4.687+2.279
TTM4.687YOY-+4.687
TTM4.6875Y2.344+2.344
5Y2.34410Y2.3440.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Total Other Income Expense Net -46,7835,381-41,4022,349-39,0536,803-32,250688,761656,511



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets43,352,789
Total Liabilities30,968,895
Total Stockholder Equity9,575,890
 As reported
Total Liabilities 30,968,895
Total Stockholder Equity+ 9,575,890
Total Assets = 43,352,789

Assets

Total Assets43,352,789
Total Current Assets24,360,612
Long-term Assets18,992,177
Total Current Assets
Cash And Cash Equivalents 5,509,578
Short-term Investments 2,073,444
Net Receivables 11,665,612
Inventory 4,983,929
Other Current Assets 128,049
Total Current Assets  (as reported)24,360,612
Total Current Assets  (calculated)24,360,612
+/-0
Long-term Assets
Property Plant Equipment 11,103,502
Long-term Assets Other 2,697,975
Long-term Assets  (as reported)18,992,177
Long-term Assets  (calculated)13,801,477
+/- 5,190,700

Liabilities & Shareholders' Equity

Total Current Liabilities20,402,535
Long-term Liabilities10,566,360
Total Stockholder Equity9,575,890
Total Current Liabilities
Short-term Debt 9,178,982
Accounts payable 766,223
Other Current Liabilities 4,633,460
Total Current Liabilities  (as reported)20,402,535
Total Current Liabilities  (calculated)14,578,665
+/- 5,823,870
Long-term Liabilities
Long-term Liabilities  (as reported)10,566,360
Long-term Liabilities  (calculated)0
+/- 10,566,360
Total Stockholder Equity
Common Stock1,015,593
Retained Earnings 4,743,256
Other Stockholders Equity 3,817,041
Total Stockholder Equity (as reported)9,575,890
Total Stockholder Equity (calculated)9,575,890
+/-0
Other
Cash and Short Term Investments 7,583,022
Common Stock Shares Outstanding 104,069
Current Deferred Revenue5,823,870
Liabilities and Stockholders Equity 43,352,789
Net Debt 13,116,743
Net Working Capital 3,958,077
Short Long Term Debt Total 18,626,321



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-30
> Total Assets 
23,048,049
22,761,215
22,809,007
20,773,029
23,429,109
25,052,005
30,659,544
43,352,789
43,352,78930,659,54425,052,00523,429,10920,773,02922,809,00722,761,21523,048,049
   > Total Current Assets 
12,451,703
12,240,806
12,362,497
10,256,376
11,206,066
10,603,028
15,850,166
24,360,612
24,360,61215,850,16610,603,02811,206,06610,256,37612,362,49712,240,80612,451,703
       Cash And Cash Equivalents 
3,202,252
3,281,319
4,807,172
4,204,772
4,136,132
3,053,294
8,065,514
5,509,578
5,509,5788,065,5143,053,2944,136,1324,204,7724,807,1723,281,3193,202,252
       Short-term Investments 
628,650
247,617
169,395
173,534
179,790
342,627
348,475
2,073,444
2,073,444348,475342,627179,790173,534169,395247,617628,650
       Net Receivables 
5,803,513
6,120,147
5,518,093
3,764,779
4,444,400
4,912,347
4,929,594
11,665,612
11,665,6124,929,5944,912,3474,444,4003,764,7795,518,0936,120,1475,803,513
       Inventory 
2,366,747
1,991,306
1,794,909
1,981,404
2,314,460
2,156,134
2,381,614
4,983,929
4,983,9292,381,6142,156,1342,314,4601,981,4041,794,9091,991,3062,366,747
       Other Current Assets 
450,541
600,417
72,928
131,887
131,284
138,626
124,969
128,049
128,049124,969138,626131,284131,88772,928600,417450,541
   > Long-term Assets 
10,596,346
10,520,409
10,446,510
10,516,653
12,223,043
14,448,977
14,809,378
18,992,177
18,992,17714,809,37814,448,97712,223,04310,516,65310,446,51010,520,40910,596,346
       Property Plant Equipment 
7,029,651
7,300,308
7,284,347
7,316,770
7,339,328
7,642,571
7,634,364
11,103,502
11,103,5027,634,3647,642,5717,339,3287,316,7707,284,3477,300,3087,029,651
       Goodwill 
586,162
983,585
983,585
983,585
983,585
2,781,388
2,781,388
0
02,781,3882,781,388983,585983,585983,585983,585586,162
       Intangible Assets 
1,632,836
1,163,846
1,130,453
1,166,936
2,309,875
2,814,282
2,747,297
0
02,747,2972,814,2822,309,8751,166,9361,130,4531,163,8461,632,836
       Long-term Assets Other 
1,347,697
1,010,643
311,537
309,721
317,674
487,490
754,043
2,697,975
2,697,975754,043487,490317,674309,721311,5371,010,6431,347,697
> Total Liabilities 
18,353,889
4,184
16,725,219
13,818,744
15,046,746
13,286,194
19,201,988
30,968,895
30,968,89519,201,98813,286,19415,046,74613,818,74416,725,2194,18418,353,889
   > Total Current Liabilities 
10,707,910
10,495,523
10,560,518
9,856,994
9,611,758
8,229,061
13,082,980
20,402,535
20,402,53513,082,9808,229,0619,611,7589,856,99410,560,51810,495,52310,707,910
       Short-term Debt 
3,388,408
2,886,692
3,002,245
4,269,686
3,225,471
1,522,894
4,736,402
9,178,982
9,178,9824,736,4021,522,8943,225,4714,269,6863,002,2452,886,6923,388,408
       Accounts payable 
399,065
454,738
395,450
408,087
483,421
361,605
339,653
766,223
766,223339,653361,605483,421408,087395,450454,738399,065
       Other Current Liabilities 
6,920,437
7,154,093
2,212,187
1,762,001
1,967,994
1,876,419
2,174,562
4,633,460
4,633,4602,174,5621,876,4191,967,9941,762,0012,212,1877,154,0936,920,437
   > Long-term Liabilities 
7,645,979
4,184
6,164,701
3,961,750
5,434,988
5,057,133
6,119,008
10,566,360
10,566,3606,119,0085,057,1335,434,9883,961,7506,164,7014,1847,645,979
> Total Stockholder Equity
4,088,722
4,528,322
5,466,463
6,329,475
7,716,847
9,084,787
8,691,297
9,575,890
9,575,8908,691,2979,084,7877,716,8476,329,4755,466,4634,528,3224,088,722
   Common Stock
753,815
753,815
775,761
1,008,308
1,013,000
1,014,981
1,015,501
1,015,593
1,015,5931,015,5011,014,9811,013,0001,008,308775,761753,815753,815
   Retained Earnings 
2,146,416
2,549,019
2,730,909
3,076,380
3,807,509
4,373,116
3,874,455
4,743,256
4,743,2563,874,4554,373,1163,807,5093,076,3802,730,9092,549,0192,146,416
   Accumulated Other Comprehensive Income 
98,539
42,200
32,466
364,133
233,625
74,660
139,232
0
0139,23274,660233,625364,13332,46642,20098,539
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
1,089,952
1,183,288
1,927,327
1,880,654
2,662,713
3,622,030
3,662,109
3,817,041
3,817,0413,662,1093,622,0302,662,7131,880,6541,927,3271,183,2881,089,952



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-09-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue14,200,068
Cost of Revenue-7,208,830
Gross Profit6,991,2386,991,238
 
Operating Income (+$)
Gross Profit6,991,238
Operating Expense-1,742,099
Operating Income4,235,3855,249,139
 
Operating Expense (+$)
Research Development298,160
Selling General Administrative996,846
Selling And Marketing Expenses447,093
Operating Expense1,742,0991,742,099
 
Net Interest Income (+$)
Interest Income0
Interest Expense-171,239
Other Finance Cost-171,239
Net Interest Income0
 
Pretax Income (+$)
Operating Income4,235,385
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)4,064,1464,406,624
EBIT - interestExpense = 4,064,146
4,022,367
3,201,381
Interest Expense171,239
Earnings Before Interest and Taxes (EBIT)4,235,3854,235,385
Earnings Before Interest and Taxes (EBITDA)4,841,671
 
After tax Income (+$)
Income Before Tax4,064,146
Tax Provision-0
Net Income From Continuing Ops04,064,146
Net Income3,030,142
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses8,950,929
Total Other Income/Expenses Net-171,2390
 

Technical Analysis of BORA PHARMACEUTICALS LTD
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BORA PHARMACEUTICALS LTD. The general trend of BORA PHARMACEUTICALS LTD is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BORA PHARMACEUTICALS LTD's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BORA PHARMACEUTICALS LTD.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 818.00 < 839.93 < 960.06.

The bearish price targets are: 709.00 > 700.10 > 700.00.

Tweet this
BORA PHARMACEUTICALS LTD Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BORA PHARMACEUTICALS LTD. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BORA PHARMACEUTICALS LTD Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BORA PHARMACEUTICALS LTD. The current macd is 10.54.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BORA PHARMACEUTICALS LTD price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for BORA PHARMACEUTICALS LTD. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the BORA PHARMACEUTICALS LTD price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
BORA PHARMACEUTICALS LTD Daily Moving Average Convergence/Divergence (MACD) ChartBORA PHARMACEUTICALS LTD Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BORA PHARMACEUTICALS LTD. The current adx is 23.43.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy BORA PHARMACEUTICALS LTD shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
BORA PHARMACEUTICALS LTD Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BORA PHARMACEUTICALS LTD. The current sar is 813.35.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BORA PHARMACEUTICALS LTD Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BORA PHARMACEUTICALS LTD. The current rsi is 61.10. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
BORA PHARMACEUTICALS LTD Daily Relative Strength Index (RSI) ChartBORA PHARMACEUTICALS LTD Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BORA PHARMACEUTICALS LTD. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BORA PHARMACEUTICALS LTD price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
BORA PHARMACEUTICALS LTD Daily Stochastic Oscillator ChartBORA PHARMACEUTICALS LTD Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BORA PHARMACEUTICALS LTD. The current cci is 110.62.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
BORA PHARMACEUTICALS LTD Daily Commodity Channel Index (CCI) ChartBORA PHARMACEUTICALS LTD Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BORA PHARMACEUTICALS LTD. The current cmo is 26.84.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BORA PHARMACEUTICALS LTD Daily Chande Momentum Oscillator (CMO) ChartBORA PHARMACEUTICALS LTD Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BORA PHARMACEUTICALS LTD. The current willr is -28.57142857.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that BORA PHARMACEUTICALS LTD is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BORA PHARMACEUTICALS LTD Daily Williams %R ChartBORA PHARMACEUTICALS LTD Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BORA PHARMACEUTICALS LTD.

BORA PHARMACEUTICALS LTD Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BORA PHARMACEUTICALS LTD. The current atr is 22.45.

BORA PHARMACEUTICALS LTD Daily Average True Range (ATR) ChartBORA PHARMACEUTICALS LTD Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BORA PHARMACEUTICALS LTD. The current obv is -4,227,071.

BORA PHARMACEUTICALS LTD Daily On-Balance Volume (OBV) ChartBORA PHARMACEUTICALS LTD Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BORA PHARMACEUTICALS LTD. The current mfi is 79.68.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
BORA PHARMACEUTICALS LTD Daily Money Flow Index (MFI) ChartBORA PHARMACEUTICALS LTD Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BORA PHARMACEUTICALS LTD.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

BORA PHARMACEUTICALS LTD Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BORA PHARMACEUTICALS LTD based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.101
Ma 20Greater thanMa 50751.800
Ma 50Greater thanMa 100748.720
Ma 100Greater thanMa 200774.901
OpenGreater thanClose780.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of BORA PHARMACEUTICALS LTD with someone you think should read this too:
  • Are you bullish or bearish on BORA PHARMACEUTICALS LTD? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BORA PHARMACEUTICALS LTD? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BORA PHARMACEUTICALS LTD

I send you an email if I find something interesting about BORA PHARMACEUTICALS LTD.


Comments

How you think about this?

Leave a comment

Stay informed about BORA PHARMACEUTICALS LTD.

Receive notifications about BORA PHARMACEUTICALS LTD in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.